Visterra(美国)

Visterra

Visterrawww.visterrainc.comVisterra发现和开发新型抗体应对重大传染病的预防和治疗。Visterradiscoversanddevelopsnovelantibodiesforthepreventionandtreatmentofmajorinfectiousdiseases.Thecompany’sproprietaryantibodyengineer ingtechnologygeneratesuniquestructuralinformationthatidentifiesnoveltargetepitopes(sitesrecognizedbyantibodies)andguidesthedesignofantibodieswhichspecificallytargettheseepitopestoeffectivelycombatdisease.Thecompany’sleadantibodyproductcandidate,VIS410,isabroadspectrummonoclonalantibodyforthepreventionandtreatmentofbothseasonalandpandemicinfluenza.Thecompanyisbuildingaproprietarypipelineofnovelantibodiesininfectiousdisease,andcontinuingtoexpanditsdiseaseareafocusthroughstrategicpartnerships.VisterrawasfoundedbasedonscientificworkdevelopedinthelaboratoryofDr.RamSasisekharanandlicensedfromMIT.ThecompanyiscurrentlybackedbyPolarisPartners,